ACE2 and COVID-19: Severe acute respiratory syndrome-related coronavirus (SARS-CoV-2), the causative agent of coronavirus disease 19 (COVID-19), gains cellular entry primarily through binding of human angiotensin-converting enzyme 2 (hACE2) by surface (spike, S) proteins [1].